Ocugen Statistics
Total Valuation
Ocugen has a market cap or net worth of MXN 5.93 billion. The enterprise value is 5.81 billion.
Market Cap | 5.93B |
Enterprise Value | 5.81B |
Important Dates
The last earnings date was Friday, May 9, 2025.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 292.03M |
Shares Outstanding | n/a |
Shares Change (YoY) | +10.88% |
Shares Change (QoQ) | +0.37% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 287.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 64.13 |
PB Ratio | 18.22 |
P/TBV Ratio | 18.22 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.95 |
EV / Sales | 67.13 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.47 |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 2.00.
Current Ratio | 2.60 |
Quick Ratio | 2.24 |
Debt / Equity | 2.00 |
Debt / EBITDA | n/a |
Debt / FCF | -0.61 |
Interest Coverage | -62.41 |
Financial Efficiency
Return on equity (ROE) is -248.97% and return on invested capital (ROIC) is -84.05%.
Return on Equity (ROE) | -248.97% |
Return on Assets (ROA) | -61.33% |
Return on Invested Capital (ROIC) | -84.05% |
Return on Capital Employed (ROCE) | -119.90% |
Revenue Per Employee | 972,892 |
Profits Per Employee | -12.37M |
Employee Count | 95 |
Asset Turnover | 0.08 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.19% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -39.19% |
50-Day Moving Average | 15.11 |
200-Day Moving Average | 17.60 |
Relative Strength Index (RSI) | 74.92 |
Average Volume (20 Days) | 260 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 16.45 |
Income Statement
In the last 12 months, Ocugen had revenue of MXN 92.42 million and -1.18 billion in losses. Loss per share was -4.20.
Revenue | 92.42M |
Gross Profit | -571.17M |
Operating Income | -1.17B |
Pretax Income | -1.17B |
Net Income | -1.18B |
EBITDA | -1.11B |
EBIT | -1.17B |
Loss Per Share | -4.20 |
Balance Sheet
The company has 772.59 million in cash and 650.43 million in debt, giving a net cash position of 122.16 million.
Cash & Cash Equivalents | 772.59M |
Total Debt | 650.43M |
Net Cash | 122.16M |
Net Cash Per Share | n/a |
Equity (Book Value) | 325.26M |
Book Value Per Share | 1.11 |
Working Capital | 553.44M |
Cash Flow
In the last 12 months, operating cash flow was -1.04 billion and capital expenditures -21.44 million, giving a free cash flow of -1.06 billion.
Operating Cash Flow | -1.04B |
Capital Expenditures | -21.44M |
Free Cash Flow | -1.06B |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -1,261.43% |
Pretax Margin | -1,271.12% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Ocugen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.88% |
Shareholder Yield | n/a |
Earnings Yield | -19.83% |
FCF Yield | -17.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Ocugen has an Altman Z-Score of -6.21. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -6.21 |
Piotroski F-Score | n/a |